(Q88018086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

K Dede

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

F Salamon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

L Landherr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

F Jakab

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

A Bursics

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

5 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

Pathology Oncology Research

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

173-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab.

19 March 2020

cites work

1 reference

12 December 2020

The timing of chemotherapy and surgery for the treatment of colorectal liver metastases

1 reference

12 December 2020

Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy.

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy

1 reference

12 December 2020

Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases

1 reference

12 December 2020

Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases

1 reference

12 December 2020

Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival

1 reference

12 December 2020

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

1 reference

12 December 2020

Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study

1 reference

12 December 2020

Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment

1 reference

12 December 2020

[Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].

1 reference

12 December 2020

Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases

1 reference

12 December 2020

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

1 reference

12 December 2020

Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

1 reference

12 December 2020

Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases

1 reference

12 December 2020

Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome

1 reference

12 December 2020

Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.

1 reference

12 December 2020

Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor

1 reference

12 December 2020

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases

1 reference

12 December 2020

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

1 reference

12 December 2020

Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

1 reference

12 December 2020

10.1007/S12253-014-9803-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24898285%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference